论文部分内容阅读
目的观察门冬氨酸钾镁治疗急性心肌梗死心律失常的临床疗效。方法 100例急性心肌梗死心律失常患者,随机分为观察组和常规组,各50例。常规组给予一般性的治疗,观察组在此基础上加用门冬氨酸钾镁进行治疗,比较两组患者治疗后的血清钾、血清镁的含量及治疗效果。结果观察组患者的有效率为96.0%,常规组为78.0%,两组比较差异具有统计学意义(P<0.05);观察组患者治疗后的血清钾、血清镁的含量均明显高于常规组,差异具有统计学意义(P<0.05)。结论采用门冬氨酸钾镁治疗急性心肌梗死心律失常患者的临床效果显著,治疗后的血清钾与血清镁的含量均较高,值得进一步推广并应用。
Objective To observe the clinical efficacy of potassium and magnesium aspartate in the treatment of arrhythmia in acute myocardial infarction. Methods 100 cases of acute myocardial infarction arrhythmia patients were randomly divided into observation group and conventional group, 50 cases each. The patients in the conventional group were given general treatment. The observation group was treated with potassium and magnesium aspartate as the basis, and the levels of serum potassium and serum magnesium and the therapeutic effect were compared between the two groups. Results The effective rate of observation group was 96.0% and that of conventional group was 78.0%, the difference between the two groups was statistically significant (P <0.05). The levels of serum potassium and serum magnesium in observation group were significantly higher than those in conventional group , The difference was statistically significant (P <0.05). Conclusion The clinical efficacy of potassium-magnesium aspartate in the treatment of patients with arrhythmia of acute myocardial infarction is remarkable. The content of serum potassium and serum magnesium are high after treatment, which is worth further promotion and application.